Thursday Aug 28
Spectrum Pharmaceuticals: A Long-Term Bet
Spectrum, a small-cap biotechnology company, has five FDA-approved drugs generating revenue and a deep pipeline for hematology and oncology treatments.
Spectrum Pharmaceuticals Inc - 10-Q - Management's Discussion and...
This Quarterly Report on Form 10-Q contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act, in reliance upon the safe harbor provisions of the Private Securities Litigation ... (more)
Spectrum Pharmaceuticals Stock Price Up 4.6% After Better-Than-Expected Earnings
Spectrum Pharmaceuticals shares rose 4.6% on Friday after the company announced better than expected quarterly earnings, ARN reports.
Spectrum Pharmaceuticals Reports 45% Sales Growth in the Second...
'The first half of the year has delivered significant growth and we are excited about the Company's sales trajectory,' said .
Onxeo SA: Key milestones and consolidated accounts First six months 2014
Major evolution of the Company, renamed Onxeo, resulting from the merger between BioAlliance Pharma and Topotarget Good progress of the major portfolio products Financial resources strengthened and expenses controlled PARIS & COPENHAGEN, Denmark-- )-- Regulatory News: Onxeo SA , an innovative company specialized in the development of drugs for ... (more)